id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-3759-0011,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry; Availability,Notice,Notice of Availability,2019-12-20T05:00:00Z,2019,12,2019-12-20T05:00:00Z,,2019-12-20T13:50:21Z,2019-27520,0,0,090000648423ff4d
FDA-2018-D-3759-0012,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry,Other,Guidance,2019-12-19T05:00:00Z,2019,12,2019-12-19T05:00:00Z,,2024-11-12T23:14:53Z,,1,0,09000064842403d5